Evaluating QuidelOrtho (QDEL): Is There Value After the Recent Share Price Rebound?

QuidelOrtho (QDEL) stock has drawn attention lately, as shares have bounced nearly 8% this week and are up over 14% for the past month. Despite recent gains, the stock’s year-to-date performance remains in negative territory.

See our latest analysis for QuidelOrtho.

After a tough stretch earlier this year, QuidelOrtho’s recent rebound is catching attention, with an 8% jump in the past week alone helping to chip away at its year-to-date share price return of -32%. Momentum appears to be picking up after prior setbacks. However, the stock remains deeply negative on a multi-year total shareholder return basis, reminding investors that there is still ground to recover as sentiment shifts.

If you’re watching for what else might be set for a turnaround, this is an ideal moment to broaden your search and discover See the full list for free.

With shares trading at a substantial discount to analyst targets and impressive recent earnings growth, investors are left to consider whether QuidelOrtho is undervalued or if the market has already accounted for its future potential.

Most Popular Narrative: 24.4% Undervalued

With a narrative fair value estimate of $40.33, QuidelOrtho’s valuation sits well above its last close price of $30.51, suggesting upside if the narrative projections play out. The numbers behind this gap are driven by bold assumptions about renewed growth and a future margin turnaround that could change the company’s trajectory.

Continued operational improvements, such as indirect procurement cost reductions, manufacturing site consolidation, and successful ERP system integration, are yielding significant margin and EBITDA gains, with incremental savings expected to directly benefit net margins and EPS into 2026 and beyond.

Read the complete narrative.

What is the secret powering this potential re-rating? The story hinges on game-changing margin improvements and some aggressive future profit forecasts, but you will need to see the precise numbers and expectations that go into this bullish scenario. Dive in to discover what justifies the analyst optimism and the sizable gap to fair value.

Result: Fair Value of $40.33 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, persistent post-pandemic revenue drag and risks from discontinued product lines could hinder QuidelOrtho’s upward trajectory if new growth drivers fail to emerge.

Find out about the key risks to this QuidelOrtho narrative.

Build Your Own QuidelOrtho Narrative

If the current analysis doesn’t reflect your own view, or you’d rather reach your own conclusions, crafting a personal narrative takes less than three minutes. Do it your way

A great starting point for your QuidelOrtho research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.

Looking for more smart investment ideas?

Take your strategy to the next level by checking out opportunities you might be missing. The right stocks could be just a click away. Don’t let them pass you by.

• Uncover opportunities in artificial intelligence by tapping into these 27 AI penny stocks and see which companies are redefining what is possible in this fast-moving sector.
• Secure reliable returns and steady income when you evaluate these 17 dividend stocks with yields > 3%, and put high-yield performers on your radar.
• Position yourself at the forefront of innovation by searching for these 27 quantum computing stocks, and get ahead with companies driving quantum breakthroughs.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com